Public Release: 31-Mar-2016
NIH-funded research could aid quest for vaccines, drugs
NIH/National Institute of Allergy and Infectious Diseases
IMAGE: A representation of the surface of the Zika virus with protruding envelope glycoproteins (red) shown.
Credit: Courtesy of Kuhn and Rossmann research groups, Purdue University
A near-atomic level map of Zika virus shows its structure to be largely similar to that of dengue virus and other flaviviruses, but with a notable difference in one key surface protein, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The variation in the Zika envelope (E) glycoproteins– 180 of which are packed on the virus’s outer shell– may provide clues to better understand how Zika virus enters human cells and suggests ways to combat the virus with drugs or vaccines aimed at the newly detailed region.
NIAID grantees Richard Kuhn, Ph.D., Michael Rossmann, Ph.D., and their colleagues at Purdue University created the picture of a mature Zika virus particle with a technique called cryo-electron microscropy. The process involves freezing virus particles and firing a stream of high-energy electrons through the sample to create tens of thousands of two-dimensional electron micrograph images that are then combined to yield a composite high-resolution, three-dimensional view of the virus. The team included NIAID investigator Theodore Pierson, Ph.D.
The difference visualized by the researchers is in a region of the E glycoprotein that flaviviruses may use to attach to some human cells. The variation in the E glycoprotein of Zika virus could explain the ability of the virus to attack nerve cells, as well as the associations of Zika virus infection with birth defects and the autoimmune-neurological Guillian-Barré syndrome. The structure could inform vaccine development, as the Zika E glycoprotein is a key target of immune responses against the virus. The information may also be useful for designing treatments such as antiviral drugs or antibodies that interfere with E glycoprotein function. Further, details on the structural differences between E glycoprotein of Zika virus and the same protein in dengue virus may make it possible to create diagnostic tests that can distinguish Zika virus infection from dengue infection, a critical need in countries where both Zika and dengue viruses are circulating.
ARTICLE: D Sirohi et al. The 3.8Å resolution cryo-EM structure of Zika virus. Science DOI: 10.1126/science.aaf5316 (2016).
WHO: The following individuals are available to comment on the research:
- NIAID Director Anthony S. Fauci, M.D.
- Theodore Pierson, Ph.D., of NIAID’s Laboratory of Viral Diseases, a co-author on the paper
- Cristina Cassetti, Ph.D., of NIAID’s Division of Microbiology and Infectious Diseases
CONTACT: To schedule interviews with NIAID experts, please contact Anne A. Oplinger, (301) 402-1663, firstname.lastname@example.org.
NOTE: Contact Elizabeth Gardner, Purdue University, at email@example.com or (765) 494-2081 for audiovisual content about this research and to request interviews with Purdue University researchers Richard Kuhn and Michael Rossmann.
This research was supported by NIAID grants R01AI073755 and R01AI076331.
NIAID conducts and supports research–at NIH, throughout the United States, and worldwide–to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH…Turning Discovery Into Health®